ERBB2 and neoplasm: Advanced imaging techniques such as MRI, elastography, and PET/CT have demonstrated potential in correlating with tumor biology, particularly in differentiating aggressive subtypes like TNBC and HER2 positive tumors based on perfusion, metabolic activity, and tissue stiffness.